EN ISO 13485 certified

  • English
  • Español
  • Français

Marle Orthopaedics Manufacturing

Manufacturing your Success

  • About us
  • Products
  • Technologies
  • Sites
  • Customer service
  • Quality
  • News
  • Careers
  • Contact
  1. Home
  2. |
  3. Technologies
  4. |
  5. Casting
Technologie of casting for orthopaedic implantsCasting's technologies for orthopaedic implant

Casting

State-of-the-art investment casting technology, for precision, reliability and cost-efficiency

Marle has developed air and vacuum investment casting capabilities that benefit orthopaedic implant production in many ways.

  • Large freedom of design, well suited to shoulder and knee implants
  • Vast choice of medical- specific alloys and superalloys
  • Tight dimensional tolerances
  • High reproducibility and consistency
  • Specific heat treatment to enhance physical and chemical properties

Marle maintains a complete, high production investment casting facility of 5800 m². Over 170 tons of cobalt and nickel base alloys are used to cast the 35 000 monthly orthopaedic parts.

With two casting lines each comprised of an induction furnace and a cluster firing furnace, Marle’s production facilities offer reactivity and flexibility regardless of volume.

  • Technologies
  • Engineering
  • Forging
  • Casting
  • Machining
  • Finishing & polishing
  • Coating
  • Cleaning & packaging
Contact us
BSI Assurance Mark ISO 13485MD 559928

News

  • Marle at the Elysée to present its Made in France product

    Elysee Palace Our site Etablissements Maurice Marle in Nogent (52800) was selected from 1750 candidates to represent the department of Haute-Marne, during the Great Exhibition of Made in France. >>

  • Marle to exhibit for the first time in China!

    COA 2019 logo Marle Group to exhibit for the first time in China, for the 14th Annual Congress of Chinese Orthopaedic Association, in Shanghai, from 15th to 17th November 2019. >>

  • A new shareholder to accompany Marle Group development

    Logo Dentressangle DENTRESSANGLE, the family-investment holding company, has entered into exclusive negotiations to acquire a majority stake in MARLE. >>

  • Terms and Conditions